Malaysian Company And Royal Prima Hospital Medan To Offer Stem Cell Treatment

By Ahmad Fuad Yahya SURABAYA, Nov 14 (Bernama) -- A Malaysian company, Ming Medical Services, and its Indonesian partner, the Royal Prima Hospital and Prima Medical University in Medan, North Sumatera, will undertake stem cell research next month and offer treatment of "last resort" for patients who have exhausted all treatment options. The facility will be located at the newly-opened 250-bed hospital which began operations on Dec 11. Ming Medical Services Managing Director Sean Ng said the research and treatment would be undertaken with hospitals and universities from Indonesia, Malaysia and South Korea. "Stem Cell research and treatment will cover a range of conditions including, diabetes and diabetic complications which includes, stroke, diabetic foot ulcers, blindness, dilated and cardiomyopathy (end-stage heart disease), neuropathy (peripheral nerve death), nephropathy (kidney failure) and autoimmune diseases," he said Thursday. Ming Medical Services is among 62 Malaysian companies participating at the ongoing four-day Malaysia Services Exhibition 2013 Surabaya, which began Wednesday, and is organised by the Malaysia External Trade Development Corporation. Sean said Ming Medical Services was established in 1998 to provide leading edge medical technologies and stem cell research and treatment services. It has operations and offices in the Middle East (Saudi Arabia, Kuwait, Oman, Bahrain), South East Asia (Malaysia, Thailand, Cambodia, Vietnam, Philippines, Myanmar), and North East Asia (South Korea, China). Simultaneous with the stem cell services, Ming Medical and the Royal Prima Hospital Medan will also launch a Remote/Mobile Critical Care Service for patients from Indonesia. The service is designed to provide critical care for patients at home in cities, as well as, clinics in remote towns and villages across Indonesia. It would use telecommunications broadband, 2.5G, 3G, 4G and WiFi networks and Internet Service Providers to keep a close tab on patients suffering from serious diabetic complications, such as complex or multiple organ failures, end-stage kidney disease, end-stage heart disease and failure, poorly managed diabetes and hypertension. It will also monitor elderly patients whose health was failing and required close and constant monitoring by family members, he said. Sean said the Mobile Critical Care system was designed to provide services 24 hours, seven days a week, and would monitor patients' key vital signs, identical to those offered by the world leading hospital’s intensive care unit. The system, he said would issue alerts including SMS messages, should any of the patient’s vital signs cross the critical threshold assigned by the medical specialist doctors. "The alerts will be sent to the patient, family members, Ming Medical Call Centre, patient’s doctor/medical centre. "In cases of emergencies, Ming’s partner hospital will dispatch ambulance service and provide immediate support for the patient, with GPS patient tracking," he said. -- BERNAMA